key: cord-0774738-b0mh4pvn authors: Alvarez-Garcia, Jesus; Jaladanki, Suraj; Rivas-Lasarte, Mercedes; Cagliostro, Matthew; Gupta, Arjun; Joshi, Aditya; Ting, Peter; Mitter, Sumeet S.; Bagiella, Emilia; Mancini, Donna; Lala, Anuradha title: New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19 date: 2021-05-04 journal: J Am Coll Cardiol DOI: 10.1016/j.jacc.2021.03.006 sha: b2b1646835c8b1d78da904786a936cf1be74b79c doc_id: 774738 cord_uid: b0mh4pvn nan Precipitation of heart failure (HF) has been described in the setting of coronavirus disease-2019 (COVID-19) (1), yet population-based studies are needed to provide a context within which the frequency of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2)-related HF can be appreciated (2, 3 p ΒΌ 0.947), but had more frequent ICU requirement and intubation and lower in-hospital mortality compared with new HF patients with CVRF or CVD, respectively ( Figure 1B) . Jesus Alvarez-Garcia, MD, PhD Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC focus seminar Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Prognostic impact of prior heart failure in patients hospitalized with COVID-19 The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.